Veriskin, Inc.
TruScore, a handheld non-invasive device that detects force-induced hemodynamic changes in skin lesions to objectively score malignancy probability (0–100 scale)
- Sector
- Medtech
- Headquarters
- San Diego, CA
- Founded
- 2016
- Latest Form D
- $682K, Nov 2020
- Total capital
- $8.3M
- Federal grants
- $7.6M
- 9 awards · 2016–2024
- Rank in peer group#76 of 538
- Private capital raised
- $682K
- 1 Form D · last Nov 2020
- 72 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 2
- 4 pending · first 2021
- Rank in peer group#190 of 538
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase II · Pivotal Clinical Study of the TruScore Device for Non-Invasive Skin Cancer Diagnostics$743K
- Federal grantHealth and Human S · Phase II · Pivotal Clinical Study of the TruScore Device for Non-Invasive Skin Cancer Diagnostics$757K
- Federal grantHealth and Human S · Phase II · Pivotal Clinical Study of the TruScore Device for Non-Invasive Skin Cancer Diagnostics$2.3M
- Federal grantHealth and Human S · Phase II · Clinical performance of hemodynamics-based non-invasive device for skin cancer testing$833K
- Private capital raisedForm D · SEC · 1st filing$682K
- Federal grantHealth and Human S · Phase II · Clinical performance of hemodynamics-based non-invasive device for skin cancer testing$1.2M
- Federal grantHealth and Human S · Phase II · Hemodynamic Noninvasive Skin Cancer Diagnostics$2K
Show 3 earlier federal awards
- Federal grantHealth and Human S · Phase II · Hemodynamic Noninvasive Skin Cancer Diagnostics$897K
- Federal grantHealth and Human S · Phase II · Hemodynamic Noninvasive Skin Cancer Diagnostics$521K
- Federal grantHealth and Human S · Phase II · Hemodynamic Noninvasive Skin Cancer Diagnostics$456K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Federal first
54months
from Veriskin, Inc.’s first federal award to its first private round.
- First federal award · Apr 2016
- Health and Human S · $456K
- First Form D · Nov 2020
- $682K · 1st Form D
- Awards before first raise
- 5 awards
An association in public records, not a cause or a prediction.
Standing among 538 peers
Line = medianMedtech · Device
- Federal grants#76 · top 14%
- Granted patents#190 · top 35%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Mirianas ChachisvilisResearcherExecutive Officer, DirectorLinked by 2 patents · $7.6M in grants as PI
- Carl EdmanDirectorNamed in SEC Form D filings
- Eugene TuDirectorNamed in SEC Form D filings
- John FitzgibbonDirectorNamed in SEC Form D filings
- Kevin HerzbergDirectorNamed in SEC Form D filings
What it has protected
USPTO · 2 granted of 6- PendingSkin Perfusion Monitoring DeviceUSPTOApplication 18481891
- GrantedSkin Perfusion Monitoring DeviceUSPTOUS 11,826,130
- GrantedSkin Perfusion Monitoring DeviceUSPTOUS 11,089,969
Show all 6 patent records
- Skin Perfusion Monitoring DeviceAug 29, 2024 · Application 18481891Pending
- Skin Perfusion Monitoring DeviceNov 28, 2023 · US 11,826,130Granted
- Skin Perfusion Monitoring DeviceAug 17, 2021 · US 11,089,969Granted
- Cutaneous Blood Flow Monitoring DeviceMay 31, 2018 · Application 15574126Pending
- Cutaneous Blood Flow Monitoring DeviceApplication PCTUS2016032738Pending
- Skin Perfusion Monitoring DeviceApplication PCTUS2014068909Pending
Related companies, and why
- AMES TECHNOLOGY, INC.Similar federal contract value in Medtech · null in contracts
- OnLume Inc.Similar federal contract value in Medtech · null in contracts
- Polyvascular CorpSimilar federal contract value in Medtech · null in contracts
- TAUVISION, INC.Similar federal contract value in Medtech · null in contracts
- Kneevoice, Inc.Similar federal contract value in Medtech · null in contracts
- Ideal Medical Technologies Inc.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .